Clinical Trials · NCT00311636
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Gruppo Italiano Mammella (GIM)
- Enrollment
- 280
- Start date
- Sep 2003
- Locations
- 18 sites, Italy
- Primary endpoint
- Chemotherapy-induced early menopause as measured by follicle-stimulating hormone, 17 beta estradiol levels, and menstrual activity resumption at 1 year following the completion of chemotherapy